USPSTF Recommendations for BRCA1 and BRCA2 Testing in the Context of a Transformative National Cancer Control Plan
Open Access
- 2 August 2019
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 2 (8) , e1910142
Abstract
In the August 20, 2019, issue of JAMA, the US Preventive Services Task Force (USPSTF) offers updated recommendations for risk assessment, counseling, and genetiKeywords
This publication has 20 references indexed in Scilit:
- Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutationsBreast Cancer Research and Treatment, 2018
- Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA MutationAmerican Journal of Preventive Medicine, 2018
- National Estimates of Genetic Testing in Women With a History of Breast or Ovarian CancerJournal of Clinical Oncology, 2017
- Faculty Opinions recommendation of Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease.2017
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular DiseaseNew England Journal of Medicine, 2017
- The State of Cancer Care in America, 2016: A Report by the American Society of Clinical OncologyJournal of Oncology Practice, 2016
- A high frequency of BRCA mutations in young black women with breast cancer residing in FloridaCancer, 2015
- How to know when physicians are ready for genomic medicineScience Translational Medicine, 2015
- Inherited predisposition to breast cancer among African American womenBreast Cancer Research and Treatment, 2014
- Prevalence and Type ofBRCAMutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research NetworkJournal of Clinical Oncology, 2013